1. Opportunities and challenges of targeting c-Met in the treatment of digestive tumors
   Zhengchao Zhang et al, 2022, Frontiers in Oncology CrossRef
2. A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients
   Herbert J. Zeh et al, 2020, Clinical Cancer Research CrossRef
3. Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors
   Máté Posta et al, 2023, Clinical and Translational Science CrossRef
4. HGF/c-Met Axis: The Advanced Development in Digestive System Cancer
   Zhiwei Shao et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
5. Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer
   Chen-Yu Hu et al, 2019, Frontiers in Oncology CrossRef
6. Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library
   Motahareh Mortazavi et al, 2023, European Journal of Pharmacology CrossRef
7. Pre-clinical Models of Metastasis in Pancreatic Cancer
   Maria Miquel et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
8. Investigation into metastatic processes and the therapeutic effects of gemcitabine on human pancreatic cancer using an orthotopic SUIT‑2 pancreatic cancer mouse model
   Tamami Higuchi et al, 2017, Oncology Letters CrossRef
9. Molecular mediators of peritoneal metastasis in pancreatic cancer
   Leela Rani Avula et al, 2020, Cancer and Metastasis Reviews CrossRef
10. The Role of Signaling Pathways in Pancreatic Cancer Targeted Therapy
    Fangfang Zhuo et al, 2023, American Journal of Clinical Oncology CrossRef
11. Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature
    Yunhao Wu et al, 2023, Scientific Reports CrossRef
12. Identification of Key Genes and Pathways in Pancreatic Cancer Gene Expression Profile by Integrative Analysis
    Wenzong Lu et al, 2019, Genes CrossRef
13. Targeting HGF/c-MET Axis in Pancreatic Cancer
    Srinivasa P. Pothula et al, 2020, International Journal of Molecular Sciences CrossRef
14. Targeting the Stroma in the Management of Pancreatic Cancer
    Penelope Edwards et al, 2021, Frontiers in Oncology CrossRef
15. Targeting the nucleic acid oxidative damage repair enzyme MTH1: a promising therapeutic option
    Yifeng Ding et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
16. Three Immune-Related Prognostic mRNAs as Therapeutic Targets for Pancreatic Cancer
    Cangang Zhang et al, 2021, Frontiers in Medicine CrossRef
17. Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC
    Malene Nielsen et al, 2021, Journal of Clinical Pathology CrossRef
18. MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer
    Xinxue Zhang et al, 2022, Journal of Oncology CrossRef